Literature DB >> 17995984

Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment.

Ling Yeung1, Ko-Jen Yang, Tun-Lu Chen, Nan-Kai Wang, Yen-Po Chen, Wan-Chen Ku, Chi-Chun Lai.   

Abstract

PURPOSE: To elucidate the relationship between the severity of vitreous haemorrhage (VH) and visual outcome in primary rhegmatogenous retinal detachment (RRD) without previous vitreoretinal surgery.
METHODS: We carried out a retrospective review of patients presenting with RRD and VH between January 1993 and December 2002. Diabetic retinopathy, retinal vessel occlusion and open-globe injury patients were excluded. Study patients were separated into group 1 (eyes with mild to moderate VH) and group 2 (eyes with severe VH).
RESULTS: Our sample included 71 eyes of 71 patients (mean age 48.0 years, range 7-78 years) (median follow-up period 19 months, range 12-140 months), of which 21 had mild, 17 had moderate and 33 had severe VH. The mean visual acuity (VA) in logMAR (logarithm of minimum angle of resolution) of the 38 eyes in group 1 improved from 1.90 (Snellen equivalent [SE] 20/1589) to 0.68 (SE 20/96). In the 33 eyes in group 2, mean logMAR VA improved from 2.42 (SE 20/5261) to 1.63 (SE 20/853). Group 2 patients were significantly older (p = 0.002), had longer duration of preoperative haemorrhage (p = 0.004), lower presenting VA (p < 0.001), worse final VA (p < 0.001), and a higher incidence of severe (grade C) proliferative vitreoretinopathy (PVR) (p = 0.002). More eyes in group 2 required silicone oil tamponade, although this was not statistically significant (p = 0.133). The overall recurrence rate of retinal detachment after primary surgery was around 21% in both groups.
CONCLUSIONS: Rhegmatogenous retinal detachment with severe VH is associated with longer duration of preoperative haemorrhage, a higher incidence of severe PVR and worse visual outcome. Close follow-up and aggressive surgical interventions are suggested in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17995984     DOI: 10.1111/j.1600-0420.2007.01053.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear.

Authors:  Mario Gutierrez; Jose L Rodriguez; Diego Zamora-de La Cruz; Mariana Aracely Flores Pimentel; Aida Jimenez-Corona; Linda C Novak; Rene Cano Hidalgo; Federico Graue
Journal:  Cochrane Database Syst Rev       Date:  2019-12-16

2.  Quantitative spectral domain optical coherence tomography thickness parameters in type II diabetes.

Authors:  Laxmi Gella; Rajiv Raman; Tarun Sharma
Journal:  Oman J Ophthalmol       Date:  2016 Jan-Apr

3.  A retrospective study comparing outcomes of primary rhegmatogenous retinal detachment repair by scleral buckling and pars plana vitrectomy in Finland.

Authors:  Sari Sahanne; Raimo Tuuminen; Jari Haukka; Sirpa Loukovaara
Journal:  Clin Ophthalmol       Date:  2017-03-10

4.  Early vitrectomy for dense vitreous hemorrhage in adults with non-traumatic and non-diabetic retinopathy.

Authors:  Ting Zhang; Jingjing Zhang; Xiaolei Sun; Jingyi Tian; Weiyun Shi; Gongqiang Yuan
Journal:  J Int Med Res       Date:  2017-06-19       Impact factor: 1.671

5.  Evaluation of microvascular changes in the macular area of eyes with rhegmatogenous retinal detachment without macular involvement using swept-source optical coherence tomography angiography.

Authors:  Yuji Yoshikawa; Takuhei Shoji; Junji Kanno; Hisashi Ibuki; Kimitake Ozaki; Hirokazu Ishii; Yoshikazu Ichikawa; Itaru Kimura; Kei Shinoda
Journal:  Clin Ophthalmol       Date:  2018-10-15

6.  Outcome of rhegmatogenous retinal detachment repair: Experience of a tertiary center in Oman.

Authors:  Ahmed S Al-Hinai; Mohamed S Al-Abri
Journal:  Oman J Ophthalmol       Date:  2013-09

7.  Higher Order Aberrations following Scleral Buckling Surgery in Patients with Rhegmatogenous Retinal Detachment.

Authors:  Chia-Yi Lee; Wei-Chi Wu; Ling Yeung; Hung-Chi Chen; Kuan-Jen Chen; Yen-Po Chen; Yih-Shiou Hwang; Chi-Chun Lai
Journal:  Healthcare (Basel)       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.